0001415889-23-005233.txt : 20230320 0001415889-23-005233.hdr.sgml : 20230320 20230320171656 ACCESSION NUMBER: 0001415889-23-005233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230316 FILED AS OF DATE: 20230320 DATE AS OF CHANGE: 20230320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sanj K CENTRAL INDEX KEY: 0001532218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 23747136 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-03202023_090347.xml X0407 4 2023-03-16 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001532218 Patel Sanj K C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA true true false false CHAIRMAN & CEO 0 Class A Common Share 2023-03-16 4 M 0 6569 A 28965 D Class A Common Share 2023-03-16 4 F 0 1929 11.46 D 27036 D Class A Common Share 2023-03-20 4 M 0 12002 A 39038 D Class A Common Share 2023-03-20 4 F 0 3523 11.12 D 35515 D Class A Common Share 83336 I Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Class A Common Share 109795 I Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 Restricted Share Unit 2023-03-16 4 M 0 6569 0 D Class A Common Share 6569 13138 D Restricted Share Unit 2023-03-20 4 M 0 12002 0 D Class A Common Share 12002 0 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-03-20